PROXY STATEMENT

Company

Semnur Pharmaceuticals, Inc.

Filed

June 28, 2024

Period of Report

July 10, 2024

Accession Number

0001213900-24-057300

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →